HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients

HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients have?

HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients has 158 citations in the OpenAlex counts ScholarIQ stores.

When was HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients published?

HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients has 2005 year in the ScholarIQ index.

What is the open-access status of HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients?

HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients has closed oa status in the ScholarIQ index.

What is the DOI of HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients?

The DOI for HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients is on the source record.

What is the PMID of HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients?

The PMID for HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients is on the source record.

What is the OpenAlex record for HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients?

The OpenAlex for HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients is on the source record.